Taking a CBD-only product does not make driving illegal in the UK. That is the short answer. CBD is not a controlled drug under the Road Traffic Act 1988, there is no statutory blood concentration limit for it, and clinical trials testing oral CBD up to 1500 mg found no statistically significant impairment in simulated driving performance. If your product is genuinely THC-free and you feel alert, you are not breaking drug-driving law by getting behind the wheel.
The situation changes the moment THC enters the picture. Prescribed cannabis medicines containing THC are subject to the per se limits set under Section 5A of the Road Traffic Act, and a positive roadside test can lead to prosecution even if you hold a valid prescription. The statutory medical defence exists, but it is narrow and requires careful preparation.
The practical rule for CBD and driving in the UK: use a third-party lab-tested, THC-free product, carry your certificate of analysis (COA), and do not drive if you feel drowsy or altered — regardless of what the label says.
Here is what the law actually requires, how roadside testing works, and exactly what to carry if you are ever stopped.
- CBD-only products carry no per se drug-driving limit and are unlikely to trigger a positive THC roadside test.
- Prescribed cannabis medicines containing THC are subject to very low blood concentration limits (2 μg/L for THC) under Section 5A.
- The statutory medical defence is available but narrow: lawful prescription, taken as directed, and no impairment.
- Carry your prescription, clinic letter, and product COA at all times.
- If you feel drowsy or slowed, do not drive — subjective impairment is assessed behaviourally, not just chemically.
Pro Tip: Save your product’s batch COA as a PDF on your phone. If you are ever stopped, you can show an officer the cannabinoid profile on the spot, which can speed up enquiries considerably.
Table of Contents
- What UK law actually says about CBD and driving
- How police test for drugs at the roadside — and can CBD trigger a positive?
- Does CBD actually impair your driving? What the evidence says
- What to do if you are stopped by police
- How to choose a CBD product that minimises risk for drivers
- Key takeaways
- The product transparency gap that most CBD brands ignore
- THC-free CBD options from Hempthy, with lab reports you can actually check
- Useful sources and further reading
What UK law actually says about CBD and driving
The legal framework for drug driving in the UK sits in Section 5A of the Road Traffic Act 1988, which created a per se offence for driving with specified controlled drugs above set blood concentration limits. THC is one of those specified drugs. The legal blood limit for THC is 2 μg/L, a threshold deliberately set low to target recreational use rather than therapeutic levels.
CBD is not on that list. There is no statutory limit for cannabidiol, and it is not classified as a controlled drug for the purposes of the drug-driving offence. That distinction matters enormously in practice: a driver using a verified THC-free CBD product is not committing a per se offence, full stop.
The statutory medical defence and who can rely on it
Patients prescribed cannabis medicines containing THC can invoke the statutory medical defence, but the conditions are strict. To rely on it, you must demonstrate all three of the following:
- The medicine was lawfully prescribed by a registered clinician.
- It was taken in accordance with the prescriber’s instructions and any accompanying leaflet.
- You were not impaired to drive at the time of the stop.
Department for Transport guidance for healthcare professionals is explicit: patients should carry evidence that their medicine was lawfully prescribed and taken as directed. A prescription alone is not enough if you cannot also demonstrate you were fit to drive.
DVLA notification and insurance
You are required to tell the DVLA if you have a medical condition or take medication that could affect your fitness to drive. This applies to the underlying condition being treated, not simply to CBD use. If a clinician has prescribed a cannabis medicine and advised you that it may affect your driving, that conversation should be documented and the DVLA informed where required.
Insurance is a separate concern. Failing to disclose a prescribed cannabinoid medicine to your insurer can invalidate your policy. Check your policy wording and, if in doubt, declare it.
Documents to carry
- Valid prescription or repeat prescription slip
- Clinic letter confirming the medicine, dosing schedule, and any driving advice given
- Manufacturer’s patient information leaflet
- Batch-specific COA showing cannabinoid profile (particularly THC levels)
- Any written dosing instructions from your clinician
How police test for drugs at the roadside — and can CBD trigger a positive?
Police in the UK use an oral-fluid roadside screening device as the first step. These devices are designed to detect THC, not CBD. A CBD-only product is unlikely to trigger a positive result, but a contaminated or full-spectrum product that contains even trace THC can.
If the roadside screen is positive, officers can require a blood sample. Laboratory analysis is considerably more sensitive, and blood limits for THC are set at 2 μg/L, which is very low. A positive blood result does not automatically mean prosecution, but it does place you in the position of needing to rely on the statutory medical defence, which requires the documentation listed above.
What oral-fluid devices actually detect
Roadside oral-fluid devices indicate recent THC exposure rather than current impairment. They must be followed by laboratory confirmation before any prosecution can proceed. THC can remain detectable in saliva for roughly 12 hours after use in some formulations, and in blood for longer at higher doses, well beyond the window of subjective intoxication. That gap between biochemical detection and functional impairment is exactly why carrying documentation is so important.
Officers also assess impairment behaviourally at the roadside. Field impairment tests check coordination, balance, and pupil response. A driver who appears alert and coordinated is in a materially different position from one who is visibly drowsy, even if both test positive on an oral-fluid screen.
Pro Tip: If you take a prescribed cannabis medicine, ask your clinician to write a brief letter confirming your dosing schedule and that you were advised on driving. Drivers who present this at a stop tend to have smoother interactions with police and faster resolution of enquiries.
For broader context on how THC in different product formats affects detection and impairment, this overview of THC drinks and driving covers the detection mechanics in a useful way.
Does CBD actually impair your driving? What the evidence says
The short answer from the clinical literature is: at typical consumer doses, CBD alone does not measurably impair driving performance. The longer answer involves dose, route of administration, and individual variation.
What controlled trials found
A randomised, placebo-controlled dose-ranging trial tested oral CBD at a range of doses including typical consumer levels and found no statistically significant increase in standard deviation of lateral position (SDLP), the primary measure of lane-keeping used in driving research. At the highest dose, CBD persisted in plasma for extended periods, but that persistence did not translate into measurable driving impairment.
A separate randomised cross-over experiment using vaporised CBD at commonly used doses found no significant differences in overall driving performance score or reaction times compared with placebo.
| Study | Dose tested | Route | Main outcome | Key limitation |
|---|---|---|---|---|
| Dose-ranging RCT | 1500 mg | Oral | No significant SDLP increase vs placebo | Healthy volunteers; single-dose design |
| Cross-over experiment | — | Vaporised | No significant change in driving performance score | Low doses; short follow-up |
| Narrative review | Multiple trials | Various | CBD shows negligible impairment at typical doses; THC consistently impairs | Review-level evidence; heterogeneous studies |
The somnolence caveat
CBD can produce somnolence in some people, especially at high or clinical doses. Clinicians advise treating drowsiness or slowed reactions as evidence of impairment regardless of blood levels. Statistical non-impairment at a group level does not mean every individual at a high dose will be unaffected.
Recent reviews of cannabis-impaired driving research confirm that THC consistently impairs driving and has additive effects with alcohol, while CBD’s effect on driving performance is limited at typical doses. Where CBD and THC are combined, high CBD:THC ratios may partially mitigate some THC-related impairment in limited studies, but this is not a reliable safety buffer and should not be used to justify driving after taking a THC-containing medicine.
Pro Tip: Drowsiness is the signal to act on, not the dose number. If you feel sleepy after taking CBD, treat that the same way you would treat feeling sleepy after an antihistamine: do not drive.
What to do if you are stopped by police
Staying calm and organised is the most practical thing you can do. Here is a step-by-step approach.
- Pull over safely and remain polite. Officers assess your behaviour from the moment you stop. Calm, cooperative conduct works in your favour.
- Be upfront about your medication. If you take a prescribed cannabis medicine, say so clearly: “I take a prescribed cannabis medicine. I have my prescription and clinic letter with me.”
- Offer your documentation. Present your prescription, clinic letter, and COA. You are not obliged to hand over your phone, but showing a COA PDF on screen is practical and often speeds things up.
- Comply with lawful instructions. If asked to take a roadside oral-fluid test, comply. Refusing is itself an offence.
- Do not volunteer more than necessary. Answer questions honestly but concisely. If you are unsure of your rights, you can ask to speak to a solicitor before answering further questions at a police station.
- Note the officer’s details and the time. If the stop leads to further action, this information will be useful for your solicitor.
Red flags: when not to drive at all
- You feel drowsy, slow to react, or mentally foggy after dosing.
- You have combined CBD or a cannabis medicine with alcohol, opioids, benzodiazepines, or other sedatives.
- You have recently increased your dose and have not yet assessed how the new level affects you.
- Your clinician has advised you not to drive during a particular phase of treatment.
When in doubt, check safe CBD use guidance and allow a safety window before getting behind the wheel.
When to contact your insurer and a solicitor
Tell your insurer about any prescribed cannabinoid medicine before you drive. If you are arrested or charged following a stop, contact a solicitor with experience in drug-driving cases before making any further statements.
How to choose a CBD product that minimises risk for drivers
Product choice is where you have the most control. The type of CBD product you use directly affects your exposure to THC and therefore your legal and testing risk.
Understanding the three product types
- Broad-spectrum CBD: — Contains multiple cannabinoids but with THC removed during processing. Usually THC-free, but always verify with a batch-specific COA because processing standards vary.
- Full-spectrum CBD: — Contains the full cannabinoid profile including THC, typically up to 0.2% by dry weight in UK-legal products. Trace THC can accumulate with regular use and may be detectable in blood tests. Higher risk for drivers, particularly those subject to random or post-incident testing.
| Product type | THC present? | Roadside test risk | Statutory limit applies? | Driver recommendation |
|---|---|---|---|---|
| CBD isolate | No | Very low | No | Lowest risk |
| Broad-spectrum | Usually no (verify COA) | Low if COA confirmed | No (if THC-free) | Low risk with COA |
| Full-spectrum | Yes (trace) | Possible | Potentially | Higher risk; avoid if driving regularly |
How to read a COA
A certificate of analysis is a lab report from an accredited third-party laboratory showing the cannabinoid profile of a specific batch. When reviewing one:
- Check the batch number matches the product you have.
- Look for the THC result: “not detected” or below the lab’s reporting limit is what you want.
- Confirm the lab is UKAS-accredited or equivalent.
- Check the test date: a COA more than 12 months old may not reflect the current batch.
Pro Tip: Download the COA PDF for your current batch and save it alongside your product label photo on your phone. If you are stopped, you can present both in under 30 seconds.
Understanding the difference between THC and CBD at a biochemical level also helps you ask better questions when buying, and to understand exactly what a COA is telling you.
Key takeaways
CBD-only products do not trigger the UK drug-driving per se offence, but impairment from any cause remains illegal, and prescribed cannabis medicines containing THC require careful documentation and a narrow statutory medical defence.
| Point | Details |
|---|---|
| CBD is not a specified drug | No per se blood limit exists for CBD under the Road Traffic Act 1988; THC is specified at 2 μg/L. |
| Statutory medical defence is narrow | You must show a lawful prescription, correct dosing, and no impairment — all three, not just one. |
| Roadside tests detect THC, not CBD | Oral-fluid devices target THC; a THC-free COA is your practical safeguard at a stop. |
| Drowsiness overrides dose numbers | If you feel impaired, do not drive — clinicians assess fitness behaviourally, not by blood level alone. |
| Hempthy’s isolate gummies are THC-free | Made with 99.9% pure CBD isolate and batch-tested; COAs are available to verify before you drive. |
The product transparency gap that most CBD brands ignore
The clinical evidence on CBD and driving is genuinely reassuring, and I think it is worth saying that plainly rather than hedging everything into uselessness. Controlled trials at doses far higher than most people ever take found no measurable lane-keeping impairment. That is a meaningful finding, not a technicality.
What concerns me more than the pharmacology is the product quality gap. The legal risk for most CBD users in the UK is not that CBD impairs them. It is that they are using a product that contains more THC than the label claims, because the UK CBD market still has products that do not match their labels. A driver who buys a “THC-free” product without a batch-specific COA is taking a legal risk that has nothing to do with CBD’s actual effects on the brain.
The statutory medical defence is similarly misunderstood. Patients sometimes assume that holding a prescription provides complete protection. It is not. The defence requires proving you were not impaired at the time, which is genuinely difficult once a blood test shows THC above 2 μg/L. The documentation burden falls on the patient, and most people are not prepared for it.
My honest view: the safest approach for any driver who uses CBD regularly is to treat product verification as non-negotiable, not optional. Check the COA, match the batch number, and keep the PDF on your phone. That single habit closes most of the practical risk gap.
THC-free CBD options from Hempthy, with lab reports you can actually check
If you want the reassurance of a verified THC-free product before you drive, Hempthy’s approach is built around exactly that. The CBD gummy bears are made with 99.9% pure CBD isolate, meaning THC is not present in the formulation by design, not just by processing. Every batch is third-party lab tested, and the COA is available for you to check the cannabinoid profile before you buy or before you drive.
For drivers who want a broader range, Hempthy’s CBD oils include broad-spectrum options with batch COAs available on request. The practical step is simple: check the COA for your batch, confirm THC is not detected, save the PDF, and keep it with your product when you travel. That is the kind of transparency that makes a real difference when you need it.
Useful sources and further reading
- Drugs and driving: the law (GOV.UK) — the primary government page explaining the drug-driving offence, specified drugs, and limits under Section 5A of the Road Traffic Act 1988.
- Medical cannabis and road safety (Department for Transport) — the official DfT report on medical cannabis and road safety; covers the statutory medical defence and patient guidance.
- Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial (PMC) — the key RCT testing oral CBD at a range of doses including typical consumer levels; found no significant SDLP increase versus placebo.
- Visual function and vehicle driving performance under the effects of cannabidiol: A randomised cross-over experiment (PMC) — vaporised CBD at commonly used doses; no significant change in overall driving performance score.
- Recent advances in the science of cannabis-impaired driving (PMC) — narrative review distinguishing THC and CBD effects on driving; covers interaction risks and behavioural guidance for patients.
- The Effects of Cannabidiol on the Driving Performance of Healthy Adults: A Pilot RCT (PMC) — pilot trial examining oral CBD and simulated driving; notes drowsiness as a potential side effect to monitor.
